Insider · CIK 0001348587

Allen Patricia L

Reports to the SEC for 5 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001348587

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-15	ZBIOZenas BioPharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.5K sh	—	—	18,500
2026-02-13	ZBIOZenas BioPharma, Inc.P Purchase	Director	PPurchase	+4,160 sh	$26.36	+$110K	19,860
2026-02-12	ZBIOZenas BioPharma, Inc.P Purchase	Director	PPurchase	+5,000 sh	$23.77	+$119K	5,000
2026-02-12	ZBIOZenas BioPharma, Inc.P Purchase	Director	PPurchase	+5,700 sh	$24.34	+$139K	10,700
2026-02-12	ZBIOZenas BioPharma, Inc.P Purchase	Director	PPurchase	+5,000 sh	$26.50	+$133K	15,700
2025-06-10	ZBIOZenas BioPharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.5K sh	—	—	18,500
2024-09-12	ZBIOZenas BioPharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.5K sh	—	—	18,500
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.5K sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,269 sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,727 sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,181 sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.2K sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,570 sh	—	—	0
2024-01-16	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+4,727 sh	$10.58	+$50K	4,727
2023-06-21	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2023-01-17	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+3,269 sh	$15.30	+$50K	3,269
2022-06-23	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+18.5K sh	—	—	18,500
2022-01-18	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+9,570 sh	$5.22	+$50K	9,570
2021-06-23	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2021-06-02	KINETA, INC./DEStock Option (Right to Buy)A Award	Director	AAward	+14.8K sh	—	—	14,800
2020-12-22	KINETA, INC./DEStock Option (Right to Buy)A Award	Director	AAward	+5,271 sh	—	—	5,271
2020-12-22	KINETA, INC./DEStock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,495
2020-06-10	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2020-06-05	Deciphera Pharmaceuticals, Inc.S Sale	Director	SSale	−5,635 sh	$55.90	−$315K	0
2020-06-05	Deciphera Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,635 sh	$25.73	+$145K	5,635
2020-06-05	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,635 sh	—	—	0
2020-06-03	Deciphera Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,365 sh	$25.73	+$164K	6,365
2020-06-03	Deciphera Pharmaceuticals, Inc.S Sale	Director	SSale	−6,365 sh	$59.14	−$376K	0
2020-06-03	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,365 sh	—	—	5,635
2020-01-24	Deciphera Pharmaceuticals, Inc.S Sale	Director	SSale	−6,496 sh	$66.55	−$432K	700
2020-01-24	Deciphera Pharmaceuticals, Inc.C Conversion	Director	CConversion	+25K sh	$3.95	+$98.8K	25,000
2020-01-24	Deciphera Pharmaceuticals, Inc.S Sale	Director	SSale	−17.8K sh	$65.93	−$1.17M	7,196
2020-01-24	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	10,233
2020-01-24	Deciphera Pharmaceuticals, Inc.S Sale	Director	SSale	−700 sh	$67.36	−$47.2K	0
2019-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2019-01-22	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+125K sh	—	—	125,000
2018-05-17	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2018-02-22	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+125K sh	—	—	125,000
2017-10-02	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,236 sh	—	—	0
2017-10-02	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+7,181 sh	—	—	7,181
2017-10-02	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+35.2K sh	—	—	35,233
2017-10-02	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,271 sh	—	—	0
2017-01-27	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+88K sh	—	—	88,000
2016-07-26	LRMRLarimar Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+8,200 sh	$3.15	+$25.8K	19,793
2016-07-25	LRMRLarimar Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+7,800 sh	$3.08	+$24K	11,593
2016-03-31	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+72K sh	—	—	72,000
2016-03-31	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+36K sh	—	—	36,000
2015-02-27	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+60K sh	—	—	187,388

Recent filings

Accepted (ET)
Jun 174
Allen Patricia L0001104659-26-075253
SEC(opens sec.gov)
Feb 134
Allen Patricia L0001104659-26-015342
SEC(opens sec.gov)
Jun 124
Allen Patricia L0001104659-25-058933
SEC(opens sec.gov)
Sep 164
Allen Patricia L0001104659-24-100335
SEC(opens sec.gov)
Jun 114
Allen Patricia L0000950170-24-072198
SEC(opens sec.gov)
Jan 184
Allen Patricia L0000950170-24-005387
SEC(opens sec.gov)
Jun 234
Allen Patricia L0001209191-23-039324
SEC(opens sec.gov)
Jan 194
Allen Patricia L0001209191-23-003997
SEC(opens sec.gov)
Jun 244
Allen Patricia L0001209191-22-039193
SEC(opens sec.gov)
Jan 204
Allen Patricia L0001209191-22-004080
SEC(opens sec.gov)

Companies

Address

C/O ZENAS BIOPHARMA, INC. 852 WINTER ST., SUITE 250

WALTHAM, MA, 02451